I now have all the needed material. Let me compile the comprehensive MUHS exam-oriented answer.
PATHOLOGY NOTES - MUHS 2nd MBBS
Based on Robbins & Kumar Basic Pathology + Harshmohan
1. HODGKIN'S LYMPHOMA (HL)
Classification - Five Subtypes (WHO)
HL is classified as:
A. Classic Hodgkin Lymphoma (4 subtypes) - all express CD15 + CD30:
| Subtype | Frequency | Age/Sex | Key Features |
|---|
| 1. Nodular Sclerosis | Most common (~65%) | Young adults, F=M | Lacunar cells + collagen bands; mediastinal involvement |
| 2. Mixed Cellularity | ~25% | >50 yrs, M>F | Abundant classic RS cells; EBV in 70% |
| 3. Lymphocyte Rich | Uncommon | - | Many lymphocytes, few RS cells |
| 4. Lymphocyte Depleted | Rare | Elderly/HIV | Many RS cells, few lymphocytes; worst prognosis |
B. Nodular Lymphocyte Predominant HL (~5%) - SEPARATE entity; L&H "popcorn cells"; expresses CD20, NOT CD15/CD30.
MIXED CELLULARITY HL - Two Important Features (★★ Exam Favorite)
- Abundant classic Reed-Sternberg cells - Binucleate/multinucleate RS cells are plentiful in a heterogeneous inflammatory background of lymphocytes, eosinophils, plasma cells, and macrophages
- Strong EBV association - EBV is demonstrable in RS cells in up to 70% of cases (highest of all HL subtypes); the integration site is identical in all RS cells, confirming EBV infection precedes clonal transformation
Additional notable features:
- Most common subtype in patients >50 years, with male predominance
- More likely to be disseminated and associated with systemic "B symptoms" compared to nodular sclerosis
- EBV likely contributes to transformation via oncogenic LMP1 protein
REED-STERNBERG (RS) CELL - Description
Classic RS Cell (Diagnostic / "Owl-Eye" Cell)
- Size: Large, 15-45 µm in diameter
- Nucleus: Enormous multilobate nucleus (typically binucleate or bilobed)
- Nucleolus: Exceptionally prominent, large, inclusion-like, acidophilic nucleolus surrounded by a clear halo - classically two nucleoli in mirror-image lobes giving the "owl-eye" appearance
- Cytoplasm: Abundant, slightly eosinophilic
- Immunophenotype: CD15(+), CD30(+), CD45(-), B-cell and T-cell markers (-)
- Origin: Derived from germinal center B cells (proven by identical Ig gene rearrangements in single microdissected RS cells)
Histology - Classic RS cell (Robbins Fig 10.23):
Classic RS cell - binucleate, large inclusion-like nucleoli, "owl-eye" appearance
RS Cell Variants (★★ Must Know for Exam)
| Variant | Subtype found in | Features |
|---|
| Lacunar cell | Nodular Sclerosis | Single multilobate nucleus, multiple small nucleoli, pale cytoplasm retracts in formalin leaving nucleus in empty "lacune" |
| L&H cell ("Popcorn cell") | Nodular Lymphocyte Predominant | Delicate multilobed nucleus resembling popcorn; expresses CD20, NOT CD15/CD30 |
| Mononuclear variant (Hodgkin cell) | All classic subtypes | Single large nucleus with prominent nucleolus; considered a forme fruste of RS cell |
| Reticular/pleomorphic variant | Lymphocyte Depleted | Bizarre anaplastic multinucleated giant cells |
GROSS AND MICROSCOPIC FEATURES (Pg. 348 reference = Harshmohan equivalent)
Gross Features
- Affected lymph nodes are enlarged, rubbery, matted, and discrete
- In Nodular Sclerosis type: the lymph node is firm due to fibrous bands and may show a white-glistening cut surface
- Involved nodes may coalesce into large masses, particularly in the mediastinum
- Spleen, liver, bone marrow involvement shows irregular nodules of RS cells mixed with reactive cells
Microscopic Features
Key principle: The diagnosis rests on identification of RS cells or variants in the appropriate reactive background.
Nodular Sclerosis (Histology):
- Lacunar cells in cellular nodules
- Collagen bands divide tissue into circumscribed nodules
- Background: lymphocytes, eosinophils, plasma cells
Histology - Nodular Sclerosis, low power (collagen bands dividing tumor into nodules):
Nodular Sclerosis HL: Pink collagen bands encircling cellular nodules (low power, H&E)
Mixed Cellularity (Histology):
- Classic RS cells plentiful
- Heterogeneous infiltrate: lymphocytes, eosinophils, plasma cells, macrophages
- No collagen bands
Histology - Mixed Cellularity (Robbins Fig 10.26):
Mixed Cellularity HL: Diagnostic binucleate RS cell surrounded by eosinophils, lymphocytes, and histiocytes
Nodular Lymphocyte-Predominant:
- "Popcorn cells" within large nodules of small B cells + macrophages
- Eosinophils scanty/absent; classic RS cells rare
Histology - Nodular LP type:
Nodular LP HL: Numerous lymphocytes with scattered large pale "popcorn cells" (L&H variant RS cells)
Pathogenesis (Quick Points)
- RS cells derive from germinal center B cells (proven by identical Ig gene rearrangements)
- EBV encodes LMP1 (a functional mimic of CD40) - most important in mixed cellularity
- RS cells secrete: IL-5 (eosinophil recruitment), TGF-β (fibrosis), IL-13 (autocrine growth)
- RS cells overexpress PD-L1 and PD-L2 → suppress host T-cell response (explains response to anti-PD-1 therapy)
Clinical Features and Staging
Clinical Features:
- Painless lymphadenopathy (most common presentation)
- B symptoms: fever, night sweats, >10% weight loss
- Pruritus
- Spreads in a stepwise/contiguous fashion (unlike NHL)
- Rarely involves mesenteric nodes or Waldeyer's ring
Ann Arbor Staging:
| Stage | Definition |
|---|
| I | Single lymph node region |
| II | ≥2 node regions, same side of diaphragm |
| III | Both sides of diaphragm |
| IV | Disseminated - multiple extralymphatic organs |
Add "A" = no B symptoms; "B" = fever, night sweats, weight loss
Prognosis: Overall excellent; 5-year survival ~90% with current chemotherapy (ABVD regimen).
2. SPLENOMEGALY - Classification and Associated Diseases
Definition
The spleen responds to most systemic diseases by enlarging. Splenomegaly produces: discomfort/dragging pain, hypersplenism (anemia, leukopenia, thrombocytopenia - especially thrombocytopenia due to platelet sequestration in red pulp).
Classification with Associated Diseases (Table 10.12, Robbins)
I. INFECTIONS
- Nonspecific splenitis (blood-borne infections, especially infective endocarditis)
- Infectious mononucleosis (EBV) - risk of splenic rupture
- Tuberculosis
- Typhoid fever
- Brucellosis
- Cytomegalovirus (CMV)
- Syphilis
- Malaria (massive splenomegaly/"Tropical splenomegaly")
- Histoplasmosis
- Toxoplasmosis
- Trypanosomiasis
- Schistosomiasis
- Leishmaniasis (kala-azar - massive splenomegaly)
- Echinococcosis
II. CONGESTIVE STATES (related to Portal Hypertension)
- Cirrhosis of the liver (most common cause of massive congestive splenomegaly)
- Portal vein thrombosis
- Splenic vein thrombosis
- Cardiac failure (congestive heart failure)
III. LYMPHOHEMATOGENOUS DISORDERS
- Hodgkin lymphoma
- Non-Hodgkin lymphomas and lymphocytic leukemias
- Myeloproliferative neoplasms (CML, polycythemia vera, primary myelofibrosis - massive splenomegaly)
- Hemolytic anemias (hereditary spherocytosis, thalassemia, sickle cell)
IV. IMMUNOLOGIC / INFLAMMATORY CONDITIONS
- Rheumatoid arthritis (Felty's syndrome: RA + splenomegaly + neutropenia)
- Systemic Lupus Erythematosus (SLE)
V. STORAGE / CONGENITAL (Lipid Storage Diseases)
- Gaucher disease (most common - massive splenomegaly)
- Niemann-Pick disease
- Mucopolysaccharidoses
VI. MISCELLANEOUS
- Amyloidosis
- Primary neoplasms and cysts (hemangioma - most common benign tumor)
- Secondary (metastatic) neoplasms
Quick Memory Aid for Splenomegaly Causes:
"I CAN LIST"
I - Infections (malaria, TB, EBV)
C - Congestive (portal HTN, cirrhosis)
A - Autoimmune (SLE, RA)
N - Neoplasms (lymphomas, leukemias)
L - Lipid storage (Gaucher, NPC)
I - Inflammatory
S - Storage disorders
T - Thalassemia/hemolytic anemias
3. NON-HODGKIN'S LYMPHOMA (NHL) - Detailed
Definition
NHL is a heterogeneous group of malignant lymphomas arising from lymphoid cells at various stages of differentiation (B cells - majority; T cells; rarely NK cells). Unlike HL, they are generally disseminated at diagnosis and spread non-contiguously.
Classification - By Cell of Origin + Grade
WHO Classification Principles:
- Based on cell of origin (B cell vs T cell vs NK cell)
- Stage of differentiation (precursor vs mature/peripheral)
- Growth pattern (follicular vs diffuse)
- Grade (indolent/low grade vs aggressive/high grade)
B-CELL NHLs (most common - ~85% of all NHL)
1. Small Lymphocytic Lymphoma / Chronic Lymphocytic Leukemia (SLL/CLL)
- Most common adult leukemia (CLL)
- Cell type: Mature CD5+ B cells
- Histology: Diffuse effacement of lymph node architecture with proliferation centers (pseudofollicles containing larger prolymphocytes) - pathognomonic
- High BCL2 expression (antiapoptotic)
- Indolent course; immune abnormalities (autoimmune hemolytic anemia, hypogammaglobulinemia)
- ~10% transform to aggressive DLBCL (Richter transformation)
- Key exam: CD5(+), CD23(+), CD20(dim+)
2. Follicular Lymphoma
- Most common indolent lymphoma (~20% of all NHL in adults)
- Cell type: Germinal center B cells
- Key genetic lesion: t(14;18) - juxtaposes BCL2 gene with IgH locus → BCL2 overexpression → blocked apoptosis
- Histology: Back-to-back follicles recapitulating germinal center B-cell growth; follicles are uniform, closely packed, lack polarization; mantle zones thin/absent
- Indolent but incurable with standard therapy
- 30-40% transform to aggressive DLBCL
- Key exam: CD10(+), BCL2(+), BCL6(+)
3. Mantle Cell Lymphoma
- Cell type: Mature CD5+ B cells (like CLL but different)
- Key genetic lesion: t(11;14) → Cyclin D1 overexpression (diagnostic marker)
- Moderately aggressive; poor prognosis
- Involves mantle zone of lymphoid follicles
- Key exam: CD5(+), CD23(-), Cyclin D1(+)
4. Extranodal Marginal Zone Lymphoma (MALT lymphoma)
- Arises at extranodal sites with chronic inflammation: stomach (H. pylori), salivary glands (Sjögren's), thyroid (Hashimoto's), lung
- Mature B cells; expresses CD20 and surface IgM
- Forms lymphoepithelial lesions (tumor cells infiltrate epithelium)
- Eradication of H. pylori causes regression of gastric MALT lymphoma (important exam point)
- Localized, indolent; often cured by excision + radiotherapy
5. Diffuse Large B-Cell Lymphoma (DLBCL)
- Most common type of lymphoma in adults (~35% of adult NHL)
- Aggressive; heterogeneous group
- Key genetic lesions:
- BCL6 rearrangements (3q27) - ~1/3 of cases
- t(14;18) with BCL2 - ~30% (may be "transformed" follicular lymphoma)
- MYC translocations
- Histology: Large cells (3-4x resting lymphocyte), round/oval nuclei, dispersed chromatin, distinct nucleoli, pale cytoplasm; diffuse growth pattern; architectural effacement
- Immunophenotype: CD20(+), CD45(+)
- ~50% cured with aggressive chemotherapy (R-CHOP)
- "Double-hit" lymphoma (BCL2 + MYC rearrangements) = very aggressive
6. Burkitt Lymphoma
- Very aggressive B-cell tumor
- Mostly extranodal (jaw in endemic African form; abdominal in sporadic form)
- Key genetic lesion: t(8;14) - MYC translocation (also t(2;8) or t(8;22)) → MYC overexpression
- EBV strongly associated with endemic (African) form; less so in sporadic
- Histology: "Starry-sky" pattern - sheets of medium-sized uniform blastic cells with numerous mitotic figures + scattered pale macrophages (tangible-body macrophages) giving a starry-sky appearance
- Immunophenotype: CD20(+), CD10(+), BCL6(+), BCL2(-), Ki-67 ~100%
- Potentially curable with intensive chemotherapy
7. Hairy Cell Leukemia (HCL)
- Rare indolent B-cell tumor
- Cells have characteristic "hairy" cytoplasmic extensions
- Massive splenomegaly + cytopenias (characteristic clinical triad)
- BRAF mutation (V600E) - diagnostic; excellent response to BRAF inhibitors and cladribine
- Tartrate-resistant acid phosphatase (TRAP) positive
T-CELL NHLs (~15% of all NHL)
8. Mycosis Fungoides (MF) / Sézary Syndrome (SS)
- Tumor of CD4+ skin-homing T cells
- MF: Indolent, localized skin involvement; responds well to topical therapy
- Histology: Pautrier microabscesses (clusters of atypical T cells in epidermis)
- SS: Leukemic variant with diffuse erythroderma and circulating tumor cells; aggressive
- Key exam: CD4(+), CD7(-) (aberrant T-cell phenotype)
9. Adult T-Cell Leukemia/Lymphoma (ATLL)
- Caused by HTLV-1 retrovirus (only human cancer caused by a retrovirus - ★exam)
- CD4(+) T cells expressing high levels of CD25 (IL-2 receptor α chain)
- Clinical: Skin lesions, lymphadenopathy, hepatosplenomegaly, hypercalcemia (osteoclast activating factors)
- Peripheral blood: cells with markedly irregular nuclear contours ("flower cells")
- Aggressive; median survival ~8 months
10. Peripheral T-Cell Lymphoma (PTCL, NOS)
- Heterogeneous group (~10% adult NHL)
- Lack defining features; "not otherwise specified"
- Aggressive; respond poorly to therapy
- Produce cytokines causing systemic symptoms even at low tumor burden
KEY DIFFERENCES: HL vs NHL (★★ Must Know)
| Feature | Hodgkin Lymphoma | Non-Hodgkin Lymphoma |
|---|
| Node involvement | Single axial group (cervical, mediastinal, paraaortic) | Multiple node groups |
| Spread | Orderly, contiguous | Non-contiguous |
| Mesenteric nodes | Rarely involved | Commonly involved |
| Waldeyer's ring | Rarely involved | Commonly involved |
| Extranodal involvement | Uncommon | Common |
| Staging at diagnosis | Often early stage | Often disseminated |
| Diagnosis | Requires tissue biopsy (RS cells) | Various subtypes by biopsy + immunophenotype |
| Prognosis | Generally excellent | Varies widely by subtype |
QUICK EXAM SUMMARY TABLE: NHL subtypes
| Lymphoma | Key Marker | Key Genetic Lesion | Grade |
|---|
| CLL/SLL | CD5+, CD23+ | - | Indolent |
| Follicular | CD10+, BCL2+ | t(14;18) | Indolent |
| Mantle cell | CD5+, Cyclin D1+ | t(11;14) | Moderate |
| MALT | CD20+ | H. pylori assoc. | Indolent |
| DLBCL | CD20+ | BCL6, BCL2, MYC | Aggressive |
| Burkitt | CD10+, Ki-67~100% | t(8;14) MYC | Very aggressive |
| Hairy cell | TRAP+, BRAF V600E | BRAF | Indolent |
| ATLL | CD25+ CD4+ | HTLV-1 retrovirus | Aggressive |
| Mycosis fungoides | CD4+, CD7- | - | Indolent |
Easy Diagrams to Draw in Exam
1. Reed-Sternberg Cell (draw this for any HL question)
___________
/ \
| O[nucleolus]| <-- Nucleus 1 with large eosinophilic nucleolus
| (halo) | surrounded by clear halo
\___________/
|
| "Owl-eye"
_____|_____
/ \
| O[nucleolus]| <-- Mirror-image Nucleus 2
| (halo) |
\___________/
Abundant eosinophilic cytoplasm all around
Background: lymphocytes + eosinophils + plasma cells
2. Nodular Sclerosis HL (draw for microscopy question)
|===Collagen band===|===Collagen band===|===Collagen band===|
| | | |
| [Lacunar cell] | [Lacunar cell] | [Lacunar cell] |
| lymphocytes | lymphocytes | lymphocytes |
| eosinophils | eosinophils | eosinophils |
| Nodule 1 | Nodule 2 | Nodule 3 |
|___________________|___________________|___________________|
3. Burkitt "Starry-Sky" Pattern (draw for NHL question)
●●●●●●●●●●●●●●●●●●●● (dark tumor cells = the "night sky")
●●● ☆ ●●●●●●● ☆ ●●● (pale macrophages = "stars")
●●●●●●●● ☆ ●●●●●●●●
●● ☆ ●●●●●●●●● ☆ ●●
●●●●●●●●●●●●●●●●●●●●
Pathogenesis Summary - B-cell NHL oncogene table
| Lymphoma | Translocation | Activated gene | Mechanism |
|---|
| Follicular | t(14;18) | BCL2 | Anti-apoptosis |
| Mantle cell | t(11;14) | Cyclin D1 | Promotes cell cycle |
| Burkitt | t(8;14) | MYC | Transcription factor, proliferation |
| DLBCL | t(3;27) | BCL6 | Transcriptional repressor |
Sources: Robbins & Kumar Basic Pathology (10th ed.), Robbins Cotran Pathologic Basis of Disease; correlation with Harshmohan Textbook of Pathology topics for MUHS 2nd MBBS exam.